Vericel Corp. (VCEL)
34.53
-0.34
(-0.98%)
USD |
NASDAQ |
May 19, 16:00
34.53
0.00 (0.00%)
After-Hours: 17:45
Vericel Research and Development Expense (Quarterly) : 8.104M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.843M |
| Arbutus Biopharma Corp. | 4.12M |
| Tenaya Therapeutics, Inc. | 14.84M |
| Moderna, Inc. | 590.00M |
| Curis, Inc. | 6.449M |